Maxim Bez
MD PhD
Maxim's research is focused on developing novel non-viral gene delivery methods for bone regeneration and bone-ligament enthesis, as well as developing non-invasive approach based on MR imaging to diagnose discogenic low back pain.
Lab Members
Dr. Zulma Gazit
PhD
Co-Principal Investigator
Dr. Zulma Gazit received a M.Sc. in Biochemistry at the University of Buenos Aires, Argentina. Later, she obtained her Ph.D. in the field of Immunology at the Hebrew University of Jerusalem. Her research focuses on Intervertebral Disc Degeneration, and the use of Induced Pluripotent Stem Cells (iPSCs) as a therapeutic approach. Besides that, she investigates the effects of teriparatide (PTH) administration on the regeneration of calvarial bone defects.
Prof. Dan Gazit
DMD, PhD
Principal Investigator
Professor Dan Gazit received a B.Sc in Biomedical Sciences and a Doctorate in Dental Medicine at the Hebrew University of Jerusalem. After specializing in oral pathology and practicing in the clinic for several years, he obtained a Ph.D. in Bone biology at the Hebrew University of Jerusalem. Since then, Prof. Dan Gazit has led numerous projects in skeletal regeneration. In his research, he has pioneered the use of genetically engineered mesenchymal stem cell and their applications in skeletal tissue repair.
Dr. Gadi Pelled
DMD, PhD
Co-Principal Investigator
Dr. Gadi Pelled received a B.Sc. in Biomedical Sciences and a Doctorate in Dental Medicine (D.M.D.) from the Hebrew University of Jerusalem, Israel. After specializing in gerodontology and oral pathology, he obtained a Ph.D. in Tissue Engineering from the Hebrew University. Since 2006 he has been a Research Scientist at the Skeletal Biotech Lab focusing on bone and tendon tissue regeneration.
Galina Shapiro
MD PhD Student
Galina's research interests include: fragility fractures, stem cell therapy, non-viral gene therapy, precision orthopedics and gender regenerative medicine.
Doron Cohn Yakubovitch
PhD
Doron develops novel stem cell-based therapeutic approaches designed to treat non-union bone fractures in a variety of anatomical sites and conditions. He is interested not only in evolving cutting edge methods, but also in eliciting the underlying molecular and cellular processes that drive successful bone regeneration. For this purpose, he created a designated imaging tool-box. In addition, Doron strives to translate these advances to the clinical arena by establishing large animal models.